Furthermore, SCFAs also help in alleviating metabolic syndrome in a high-fat-diet mouse model by inhibiting the expression of pro-inflammatory cytokines, such as IL-1β and IL-6 as well as toll like receptor 4 (TLR4) in adipose tissue (Zhai et al., 2019). The gene discussed is TLR4; the disease is metabolic syndrome.